Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6

Blood Cancer J. 2022 Apr 13;12(4):60. doi: 10.1038/s41408-022-00658-w.
No abstract available

Publication types

  • Letter
  • Meta-Analysis
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Monoclonal Gammopathy of Undetermined Significance* / genetics
  • Paraproteinemias*